Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung CancerCompleted
NCT04735068Phase 2Updated Apr 1, 2025
Sponsor: Abramson Cancer Center at Penn Medicine
Non-Small Cell Lung Cancer · KRAS Mutation-Related Tumors
United States
Breast Cancer Survivor Educational InterventionCompleted
NCT05700396NAUpdated Apr 1, 2025
Sponsor: Massachusetts General Hospital
Breast Cancer · Breast Neoplasms · Breast Carcinoma · Breast Cancer Female
United States
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.Completed
NCT05834348N/AUpdated Mar 30, 2025
Sponsor: Pfizer
Non-Small Cell Lung Cancer
Norway
A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic ArthritisCompleted
NCT05195814N/AUpdated Mar 30, 2025
Sponsor: Pfizer
Psoriatic Arthritis
United States
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine PreventionTerminated
NCT04804033Phase 2, Phase 3Updated Mar 27, 2025
Sponsor: Pfizer
Migraine
United States
Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic RhinosinusitisCompleted
NCT05248997Phase 3Updated Mar 26, 2025
Sponsor: Pfizer
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
United States
Latin American Real-world Study in Acute LeukemiaCompleted
NCT05166135N/AUpdated Mar 25, 2025
Sponsor: Pfizer
Acute Myeloid Leukemia · Acute Lymphoid Leukemia
Argentina, Brazil, Chile, Colombia
International Cardiac Amyloidosis RegistryRecruiting
NCT06894290N/AUpdated Mar 25, 2025
Sponsor: Leiden University Medical Center
Cardiac Amyloidosis
Belgium, Italy, Japan, Netherlands, Portugal
Palbociclib and Binimetinib in Advanced Triple Negative Breast CancerCompleted
NCT04494958Phase 1, Phase 2Updated Mar 24, 2025
Sponsor: Fundacion Oncosur
Triple Negative Breast Cancer
Spain
A Study to Learn About Study Medicine Called PF-07261271 in Healthy PeopleCompleted
NCT05536440Phase 1Updated Mar 24, 2025
Sponsor: Pfizer
Healthy
United States
A Sub Study to Evaluate the Study Medication (Etrasimod) Using Wearable Sensors in Healthy ParticipantsCompleted
NCT06140290Phase 1Updated Mar 24, 2025
Sponsor: Pfizer
Healthy Participants
Belgium
Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)Completed
NCT03884439N/AUpdated Mar 21, 2025
Sponsor: Pfizer
Crohn's Disease · Ulcerative Colitis
Japan
NSAA NON-Interventional Study ProtocolCompleted
NCT06054971N/AUpdated Mar 21, 2025
Sponsor: Red Nucleus Enterprise Solutions, LLC
Duchenne Muscular Dystrophy
United States
A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and NeolpharmaCompleted
NCT06205407Phase 1Updated Mar 21, 2025
Sponsor: Pfizer
Healthy Participants
United States
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)Completed
NCT04321031Phase 2Updated Mar 21, 2025
Sponsor: Pfizer
Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis With Liver Fibrosis
United States, Bulgaria, Canada, China, Hong Kong +7 more
A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.Completed
NCT05857644Phase 1Updated Mar 21, 2025
Sponsor: Pfizer
Liver Diseases · Hepatic Impairment
United States
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWithdrawn
NCT04889495N/AUpdated Mar 19, 2025
Sponsor: Pfizer
Non-small Cell Lung Cancer · Metastatic Colorectal Cancer · Metastatic Breast Cancer · Metastatic Kidney Cancer
PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple MyelomaCompleted
NCT03269136Phase 1Updated Mar 18, 2025
Sponsor: Pfizer
Multiple Myeloma
United States, Canada
Investigating Healthcare Disparities in VitiligoCompleted
NCT06097494N/AUpdated Mar 17, 2025
Sponsor: Momentum Data
Vitiligo
United Kingdom
Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone DeficiencyCompleted
NCT03525587NAUpdated Mar 14, 2025
Sponsor: Azienda Ospedaliero-Universitaria di Modena
Growth Hormone Deficiency
Italy
Improvement In Scratch Behavior And Sleep In Patients With Atopic DermatitisTerminated
NCT05200403Phase 4Updated Mar 14, 2025
Sponsor: Boston University
Atopic Dermatitis
United States
LORA-PITA IV General InvestigationCompleted
NCT03905798N/AUpdated Mar 10, 2025
Sponsor: Pfizer
Status Epilepticus
Japan
Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)Completed
NCT05399459Phase 3Updated Mar 7, 2025
Sponsor: Pfizer
Migraine
Japan
Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the USCompleted
NCT05260684N/AUpdated Mar 6, 2025
Sponsor: Pfizer
Melanoma
United States
A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of AgeCompleted
NCT05900154Phase 1Updated Mar 6, 2025
Sponsor: Pfizer
RESPIRATORY SYNCYTIAL VIRUS (RSV)
United States

Previous page Next page